Reneo Pharmaceuticals (RPHM) Q2 2023 Earnings

10AugConfirmed
Aug 22
Nov 22
Q4 2022
Q2 2023
-0.65
-0.6
-0.55
-0.5

Details

Expected EPS
-0.52
Actual EPS
-0.65
Surprise EPS
-0.13
Surprise Percent
+25%

Description

Reneo Pharmaceuticals (RPHM) has reported earnings of -0.65 per share for Q2 2023.

0 Comments

Share your thoughts